Why the study?
With only 10-20% of affected people currently diagnosed, there is an unmet need for an effective screening tool for HCM outside of the clinical setting.
Does a machine learning classifier analyzing photoplethysmography waveforms from a wearable biosensor accurately detect obstructive hypertrophic cardiomyopathy compared to healthy controls?
Does a machine learning classifier analyzing photoplethysmography waveforms from a wearable biosensor accurately detect obstructive hypertrophic cardiomyopathy compared to healthy controls?
A machine learning algorithm analyzing photoplethysmography signals from a wearable biosensor can accurately distinguish patients with obstructive hypertrophic cardiomyopathy from healthy volunteers, offering a potential noninvasive screening tool.
May support wearable oHCM screening; leaves open validation in broader, real-world populations before clinical adoption.
Hypertrophic cardiomyopathy (HCM) is a heritable disease of heart muscle that increases the risk for heart failure, stroke, and sudden death, even in asymptomatic patients. With only 10-20% of affected people currently diagnosed, there is an unmet need for an effective screening tool outside of the clinical setting. Photoplethysmography uses a noninvasive optical sensor incorporated in commercial smart watches to detect blood volume changes at the skin surface. In this study, we obtained photoplethysmography recordings and echocardiograms from 19 HCM patients with left ventricular outflow tract obstruction (oHCM) and a control cohort of 64 healthy volunteers. Automated analysis showed a significant difference in oHCM patients for 38/42 morphometric pulse wave features, including measures of systolic ejection time, rate of rise during systole, and respiratory variation. We developed a machine learning classifier that achieved a C-statistic for oHCM detection of 0.99 (95% CI: 0.99-1.0). With further development, this approach could provide a noninvasive and widely available screening tool for obstructive HCM.
No takes yet. Share an insight, caveat, or question.
Green et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: